The First Nationwide Implementation of Pharmaceutical Care Practices Through a Continuing Professional Development Approach for Community Pharmacists

Overview

Journal Int J Clin Pharm

Publisher Springer

Specialties Pharmacology
Pharmacy

Date 2022 Jun 14

PMID 35699862

Authors

Sule Apikoglu

Aysu Selcuk

Vildan Ozcan

Ecehan Balta

Meltem Turker

Ozge Durak Albayrak

Arijana Mestrovic

Michael Rouse

Arman Uney

Affiliations

Soon will be listed here.

Abstract

Background: Noncommunicable diseases account for the majority of all deaths and impose a high socioeconomic burden, causing disability and premature deaths. Pharmacists can contribute to the prevention and management of these diseases through the provision of pharmaceutical care services.

Aim: The aim of this study was to implement a nationwide practice developed by the Turkish Pharmacists' Association aiming to realize pharmaceutical care provision of standard quality to patients with asthma, chronic obstructive pulmonary disease, diabetes and hypertension at community pharmacies through a continuing professional development approach.

Setting: Community pharmacies in Turkey.

Development: A project with the involvement of all community pharmacists who were willing to participate was developed. After piloting, the 'project' turned into a 'practice' with a focus on asthma, chronic obstructive pulmonary disease, diabetes and hypertension management.

Implementation: The training process occurred as a peer-training activity. Consultants and academic staff trained the trainer pharmacists during a 3-day course. Community pharmacists (n = 6161) received training regarding pharmaceutical care, asthma, chronic obstructive pulmonary disease, diabetes and hypertension from their peer trainers (n = 341) and began to practice pharmaceutical care and follow-up of patients' outcomes on a regular basis.

Evaluation: Among all community pharmacists in Turkey (n = 26,177), 24% attended training. Among these pharmacists, 21% started to implement practice. With community pharmacists' contribution to patient care, significant improvements in the majority of the outcome parameters regarding asthma, chronic obstructive pulmonary disease, diabetes and hypertension management were noted.

Conclusion: This first nationwide practice showed us that community pharmacists can help improve the health outcomes of patients with asthma, chronic obstructive pulmonary disease, diabetes and hypertension through the provision of pharmaceutical care services.

Citing Articles

Exploring the knowledge, attitude, and practice of community pharmacists regarding pediatric asthma management in Guangdong Province, China: a cross-sectional survey study.

Lin G, Lai M, Chau C, Hu H, Ung C BMC Med Educ. 2025; 25(1):291.

PMID: 39987180 PMC: 11846212. DOI: 10.1186/s12909-025-06885-6.

Health indicators in the management of diabetes in Primary health care: Iran-package of Essential Non-communicable diseases (IraPEN) program.

Molaeipour L, Koohi F, Ostovar A, Etemad K, Hezaveh A, Yousefi E J Diabetes Metab Disord. 2025; 24(1):40.

PMID: 39801686 PMC: 11711714. DOI: 10.1007/s40200-024-01550-z.

Pharmacy practice and policy research in Türkiye: a systematic review of literature.

Gulpinar G, Pehlivanli A, Babaar Z J Pharm Policy Pract. 2024; 17(1):2385939.

PMID: 39139388 PMC: 11321099. DOI: 10.1080/20523211.2024.2385939.

The Medicines Optimisation Innovation Centre: a dedicated centre driving innovation in medicines optimisation-impact and sustainability.

Hogg A, Scott M, Fleming G, Scullin C, Huey R, Martin S Int J Clin Pharm. 2024; 46(5):1001-1009.

PMID: 39042349 PMC: 11399211. DOI: 10.1007/s11096-024-01775-1.

European Society of Clinical Pharmacy: 'Implementing and scaling sustainable clinical pharmacy'.

Scott M, Urbanczyk K, Stewart D Int J Clin Pharm. 2024; 46(2):355-356.

PMID: 38478210 DOI: 10.1007/s11096-024-01718-w.

References

Kharjul M, Braund R, Green J . The influence of pharmacist-led adherence support on glycaemic control in people with type 2 diabetes. Int J Clin Pharm. 2018; 40(2):354-359. DOI: 10.1007/s11096-018-0606-z. View

Tsuyuki R, Houle S, Charrois T, Kolber M, Rosenthal M, Lewanczuk R . Randomized Trial of the Effect of Pharmacist Prescribing on Improving Blood Pressure in the Community: The Alberta Clinical Trial in Optimizing Hypertension (RxACTION). Circulation. 2015; 132(2):93-100. DOI: 10.1161/CIRCULATIONAHA.115.015464. View

Mossialos E, Courtin E, Naci H, Benrimoj S, Bouvy M, Farris K . From "retailers" to health care providers: Transforming the role of community pharmacists in chronic disease management. Health Policy. 2015; 119(5):628-39. DOI: 10.1016/j.healthpol.2015.02.007. View

Apikoglu-Rabus S, Yesilyaprak G, Izzettin F . Drug-related problems and pharmacist interventions in a cohort of patients with asthma and chronic obstructive pulmonary disease. Respir Med. 2016; 120:109-115. DOI: 10.1016/j.rmed.2016.10.006. View

Selcuk A, Sancar M, Okuyan B, Demirtunc R, Izzettin F . The potential role of clinical pharmacists in elderly patients during hospital admission. Pharmazie. 2015; 70(8):559-62. View

Kara E, Inkaya A, Aydin Hakli D, Demirkan K, Unal S . Polypharmacy and drug-related problems among people living with HIV/AIDS: a single-center experience. Turk J Med Sci. 2019; 49(1):222-229. PMC: 7350848. DOI: 10.3906/sag-1807-295. View

Koschack J, Marx G, Schnakenberg J, Kochen M, Himmel W . Comparison of two self-rating instruments for medication adherence assessment in hypertension revealed insufficient psychometric properties. J Clin Epidemiol. 2009; 63(3):299-306. DOI: 10.1016/j.jclinepi.2009.06.011. View

Morisky D, Green L, Levine D . Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986; 24(1):67-74. DOI: 10.1097/00005650-198601000-00007. View

McPherson M, Smith S, Powers A, Zuckerman I . Association between diabetes patients' knowledge about medications and their blood glucose control. Res Social Adm Pharm. 2008; 4(1):37-45. DOI: 10.1016/j.sapharm.2007.01.002. View

10.

Davies M, DAlessio D, Fradkin J, Kernan W, Mathieu C, Mingrone G . Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2018; 41(12):2669-2701. PMC: 6245208. DOI: 10.2337/dci18-0033. View

11.

Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M . 2018 Practice Guidelines for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. Blood Press. 2018; 27(6):314-340. DOI: 10.1080/08037051.2018.1527177. View

12.

Cheema E, Sutcliffe P, Singer D . The impact of interventions by pharmacists in community pharmacies on control of hypertension: a systematic review and meta-analysis of randomized controlled trials. Br J Clin Pharmacol. 2014; 78(6):1238-47. PMC: 4256613. DOI: 10.1111/bcp.12452. View

13.

Deters M, Laven A, Castejon A, Doucette W, Ev L, Krass I . Effective Interventions for Diabetes Patients by Community Pharmacists: A Meta-analysis of Pharmaceutical Care Components. Ann Pharmacother. 2017; 52(2):198-211. DOI: 10.1177/1060028017733272. View

14.

Fathima M, Naik-Panvelkar P, Saini B, Armour C . The role of community pharmacists in screening and subsequent management of chronic respiratory diseases: a systematic review. Pharm Pract (Granada). 2013; 11(4):228-45. PMC: 3869639. DOI: 10.4321/s1886-36552013000400008. View

15.

Armour C, Bosnic-Anticevich S, Brillant M, Burton D, Emmerton L, Krass I . Pharmacy Asthma Care Program (PACP) improves outcomes for patients in the community. Thorax. 2007; 62(6):496-502. PMC: 2117224. DOI: 10.1136/thx.2006.064709. View

16.

Giraud V, Allaert F, Roche N . Inhaler technique and asthma: feasability and acceptability of training by pharmacists. Respir Med. 2011; 105(12):1815-22. DOI: 10.1016/j.rmed.2011.07.004. View

17.

Manfrin A, Tinelli M, Thomas T, Krska J . A cluster randomised control trial to evaluate the effectiveness and cost-effectiveness of the Italian medicines use review (I-MUR) for asthma patients. BMC Health Serv Res. 2017; 17(1):300. PMC: 5404667. DOI: 10.1186/s12913-017-2245-9. View

18.

Tommelein E, Mehuys E, Van Hees T, Adriaens E, van Bortel L, Christiaens T . Effectiveness of pharmaceutical care for patients with chronic obstructive pulmonary disease (PHARMACOP): a randomized controlled trial. Br J Clin Pharmacol. 2013; 77(5):756-66. PMC: 4004396. DOI: 10.1111/bcp.12242. View

19.

Hammerlein A, Muller U, Schulz M . Pharmacist-led intervention study to improve inhalation technique in asthma and COPD patients. J Eval Clin Pract. 2010; 17(1):61-70. DOI: 10.1111/j.1365-2753.2010.01369.x. View

20.

Mehuys E, Van Bortel L, De Bolle L, Van Tongelen I, Annemans L, Remon J . Effectiveness of a community pharmacist intervention in diabetes care: a randomized controlled trial. J Clin Pharm Ther. 2010; 36(5):602-13. DOI: 10.1111/j.1365-2710.2010.01218.x. View